Healthcare provider profile · identity verified

Corina I. Procell, MD

Family Practice · ALBUQUERQUE, NM · NPI 1720172117

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	999	268
Atorvastatin Calcium	Atorvastatin Calcium	877	251
Gabapentin	Gabapentin	636	125
Rosuvastatin Calcium	Rosuvastatin Calcium	632	206
Lisinopril	Lisinopril	528	157
Amlodipine Besylate	Amlodipine Besylate	407	115
Losartan Potassium	Losartan Potassium	361	112
Famotidine	Famotidine	298	89
Omeprazole	Omeprazole	285	88
Metoprolol Succinate	Metoprolol Succinate	271	78
Metformin Hcl	Metformin Hcl	264	82
Lovastatin	Lovastatin	244	69
Pantoprazole Sodium	Pantoprazole Sodium	220	83
Fluticasone Propionate	Fluticasone Propionate	207	88
Hydrochlorothiazide	Hydrochlorothiazide	197	60
Tamsulosin Hcl	Tamsulosin Hcl	190	55
Pregabalin	Pregabalin	178	38
Simvastatin	Simvastatin	177	51
Ozempic	Semaglutide	166	36
Metformin Hcl Er	Metformin Hcl	163	53
Duloxetine Hcl	Duloxetine Hcl	161	51
Potassium Chloride	Potassium Chloride	161	51
Tramadol Hcl	Tramadol Hcl	158	42
Albuterol Sulfate Hfa	Albuterol Sulfate	157	78
Alendronate Sodium	Alendronate Sodium	154	46
Trazodone Hcl	Trazodone Hcl	143	44
Escitalopram Oxalate	Escitalopram Oxalate	129	41
Allopurinol	Allopurinol	128	41
Memantine Hcl	Memantine Hcl	127	29
Furosemide	Furosemide	112	43
Montelukast Sodium	Montelukast Sodium	109	34
Venlafaxine Hcl Er	Venlafaxine Hcl	109	25
Bupropion Xl	Bupropion Hcl	104	29
Fluoxetine Hcl	Fluoxetine Hcl	104	33
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	100	28
Valsartan	Valsartan	98	24
Meloxicam	Meloxicam	92	25
Spironolactone	Spironolactone	91	30
Donepezil Hcl	Donepezil Hcl	84	27
Tizanidine Hcl	Tizanidine Hcl	78	27
Celecoxib	Celecoxib	77	22
Diclofenac Sodium	Diclofenac Sodium	76	28
Sertraline Hcl	Sertraline Hcl	74	32
Metoprolol Tartrate	Metoprolol Tartrate	73	24
Oxycodone Hcl	Oxycodone Hcl	65	15
Farxiga	Dapagliflozin Propanediol	64	15
Baclofen	Baclofen	63	21
Carvedilol	Carvedilol	63	20
Ibuprofen	Ibuprofen	60	18
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	59	19
Eliquis	Apixaban	57	17
Finasteride	Finasteride	57	15
Xarelto	Rivaroxaban	57	19
Citalopram Hbr	Citalopram Hydrobromide	55	16
Mirtazapine	Mirtazapine	55	23
Pravastatin Sodium	Pravastatin Sodium	54	17
Trulicity	Dulaglutide	54	17
Nortriptyline Hcl	Nortriptyline Hcl	53	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	53	28
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	51	40
Alprazolam	Alprazolam	49	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	49	17
Buspirone Hcl	Buspirone Hcl	47	16
Symbicort	Budesonide/Formoterol Fumarate	47	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	45	35
Ezetimibe	Ezetimibe	45	17
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	45	11
Chlorthalidone	Chlorthalidone	44	16
Ipratropium Bromide	Ipratropium Bromide	42	16
Propranolol Hcl	Propranolol Hcl	41	12
Doxycycline Monohydrate	Doxycycline Monohydrate	39	37
Hydroxyzine Hcl	Hydroxyzine Hcl	38	15
Zolpidem Tartrate	Zolpidem Tartrate	38	suppressed
Clopidogrel	Clopidogrel Bisulfate	37	13
Pioglitazone Hcl	Pioglitazone Hcl	37	13
Primidone	Primidone	37	suppressed
Colesevelam Hcl	Colesevelam Hcl	36	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	36	36
Acyclovir	Acyclovir	35	14
Atenolol	Atenolol	35	suppressed
Cephalexin	Cephalexin	35	28
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	34	suppressed
Spiriva Respimat	Tiotropium Bromide	34	13
Synthroid	Levothyroxine Sodium	34	12
Tresiba Flextouch U-100	Insulin Degludec	34	suppressed
Bupropion Hcl Sr	Bupropion Hcl	33	suppressed
Warfarin Sodium	Warfarin Sodium	33	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	32	13
Estradiol	Estradiol	32	16
Irbesartan	Irbesartan	32	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	31	suppressed
Azelastine Hcl	Azelastine Hcl	31	17
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	31	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	31	suppressed
Colchicine	Colchicine	29	suppressed
Labetalol Hcl	Labetalol Hcl	29	suppressed
Topiramate	Topiramate	29	12
Ciprofloxacin Hcl	Ciprofloxacin Hcl	27	19
Solifenacin Succinate	Solifenacin Succinate	25	suppressed
Mounjaro	Tirzepatide	24	suppressed
Prednisone	Prednisone	24	20
Tolterodine Tartrate	Tolterodine Tartrate	24	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	24	suppressed
Verapamil Er	Verapamil Hcl	24	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	23	suppressed
Methylprednisolone	Methylprednisolone	23	19
Liothyronine Sodium	Liothyronine Sodium	22	suppressed
Nitroglycerin	Nitroglycerin	22	12
Azithromycin	Azithromycin	21	16
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Naloxone Hcl	Naloxone Hcl	21	21
Diazepam	Diazepam	20	suppressed
Lactulose	Lactulose	19	11
Naproxen	Naproxen	19	suppressed
Trospium Chloride	Trospium Chloride	19	suppressed
Myrbetriq	Mirabegron	18	suppressed
Ondansetron Hcl	Ondansetron Hcl	18	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Dutasteride	Dutasteride	17	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Arnuity Ellipta	Fluticasone Furoate	16	suppressed
Insulin Aspart Flexpen	Insulin Aspart	16	suppressed
Nifedipine Er	Nifedipine	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	13
Testosterone	Testosterone	15	suppressed
Felodipine Er	Felodipine	14	suppressed
Levofloxacin	Levofloxacin	14	13
Lorazepam	Lorazepam	14	suppressed
Morphine Sulfate	Morphine Sulfate	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Temazepam	Temazepam	14	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Fluocinonide	Fluocinonide	13	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	13	suppressed
Glipizide Er	Glipizide	13	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Np Thyroid	Thyroid,pork	13	suppressed
Oxcarbazepine	Oxcarbazepine	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	12	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Doxepin Hcl	Doxepin Hcl	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Belsomra	Suvorexant	11	suppressed
Cefuroxime	Cefuroxime Axetil	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Fentanyl	Fentanyl	11	suppressed
Fluconazole	Fluconazole	11	11
Keppra	Levetiracetam	11	suppressed
Prasugrel Hcl	Prasugrel Hcl	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed
Tegretol	Carbamazepine	11	suppressed
Varenicline Tartrate	Varenicline Tartrate	11	suppressed
Verapamil Sr	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error